Elafibranor approved by NICE for primary biliary cholangitis
14th November 2024
A Way Forward for the Treatment of Obesity – British Liver Trust backs new policy calls
23rd October 2024
The PROMISE study
23rd August 2024
Green light for new liver cirrhosis trial using engineered immune cells
20th August 2024
New digital “prehab” service for people waiting for a liver transplant
25th July 2024
NAFLD, MASLD or fatty liver disease? Our approach to help everyone communicate clearly
23rd July 2024
British Liver Trust welcomes today’s announcement in the King’s Speech to restrict advertising of junk food to children
17th July 2024
New minimum standards for liver cancer surveillance in England
17th July 2024
Obeticholic acid (OCA) licensing in the UK – update following European Medicines Agency decision
12th July 2024
British Liver Trust has ambitious plans for the new Parliament
5th July 2024